Insider Trading23 Jun 2026, 11:04 am
Titan Biotech Ltd Closes Trading Window for Insider Trading
AI Summary
Titan Biotech Ltd has announced the closure of its trading window for all directors, promoters, KMPs, designated employees, and their immediate relatives. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The window will remain shut from Wednesday, July 1, 2026, until 48 hours after the declaration of the company's unaudited financial results for the quarter ended June 30, 2026. The date of the board meeting to approve these results will be communicated later.
Key Highlights
- Trading window closed for designated persons and relatives.
- Closure effective from July 1, 2026.
- Period extends post-declaration of Q1 FY27 financial results.
- Aimed at preventing insider trading activities.
- Board meeting date for results declaration to be announced.
Price Impact
More from TITANBIO